Kintor Pharmaceutical Limited
KNTPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $53 | $147 | $323 | $445 |
| Short-Term Investments | $0 | $1 | $11 | $10 |
| Receivables | $7 | $2 | $0 | $9 |
| Inventory | $3 | $2 | $0 | $0 |
| Other Curr. Assets | $0 | $19 | $37 | $8 |
| Total Curr. Assets | $63 | $172 | $371 | $473 |
| Property Plant & Equip (Net) | $168 | $166 | $191 | $191 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $143 | $157 | $149 | $149 |
| Long-Term Investments | $16 | $17 | $18 | $8 |
| Tax Assets | $0 | $0 | $0 | $23 |
| Other NC Assets | $1 | $4 | $10 | $26 |
| Total NC Assets | $329 | $343 | $368 | $397 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $392 | $515 | $740 | $869 |
| Liabilities | – | – | – | – |
| Payables | $47 | $39 | $47 | $68 |
| Short-Term Debt | $87 | $113 | $179 | $118 |
| Tax Payable | $0 | $0 | $1 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $14 | $12 | $38 |
| Total Curr. Liab. | $143 | $167 | $238 | $225 |
| LT Debt | $0 | $20 | $60 | $136 |
| Deferred Rev, NC | $3 | $3 | $19 | $20 |
| Deferred Tax Liab, NC | $30 | $31 | $31 | $31 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $33 | $54 | $110 | $186 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $4 | $7 |
| Total Liabilities | $176 | $221 | $348 | $411 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$4,023 | -$3,940 | -$3,856 | -$3,785 |
| AOCI | $5 | $24 | $16 | $61 |
| Other Equity | $4,233 | $4,210 | $4,231 | $4,182 |
| Total Equity | $216 | $294 | $392 | $458 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $392 | $515 | $740 | $869 |
| Net Debt | $35 | -$14 | -$84 | -$192 |